Dynavax Technologies has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against Covid-19 infection.
The company will provide access to its toll-like receptor 9 (TLR9) agonist adjuvant, CpG 101, to enable the development of vaccines.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData